发明公开
EP0845032A2 ISOLATED NUCLEIC ACID MOLECULES, PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-A2 AND USES THEREOF
失效
分离的核酸分子的肽与HLA-A2分子（MHC）络合物形式，及其用途
- 专利标题： ISOLATED NUCLEIC ACID MOLECULES, PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-A2 AND USES THEREOF
- 专利标题（中）： 分离的核酸分子的肽与HLA-A2分子（MHC）络合物形式，及其用途
-
申请号： EP96913954.0申请日： 1996-05-07
-
公开(公告)号： EP0845032A2公开(公告)日： 1998-06-03
- 发明人: GUILLOUX, Yannick , JOTEREAU, Francine , BOON-FALLEUR, Thierry , LUCAS, Sophie , BRICHARD, Vincent
- 申请人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 申请人地址： 1345 Avenue of the Americas New York, New York 10105 US
- 专利权人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人地址： 1345 Avenue of the Americas New York, New York 10105 US
- 代理机构： Fyles, Julie Marie
- 优先权： US19950487135 19950607
- 国际公布： WO1996040039 19961219
- 主分类号： G01N33
- IPC分类号： G01N33 ; A61K35 ; A61K38 ; A61K39 ; A61K45 ; A61K48 ; A61P35 ; A61P37 ; A61P43 ; C07K14 ; C12N1 ; C12N5 ; C12N15
摘要：
New tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as NAG tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as NAG coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are discribed.
信息查询
